ARCHIVES

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

This article is from The Cancer Letter archive.

Vol. 29 No. 04 | January 24, 2003

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

NCI Preliminary Budge For 1979 By Mechanism

June 3, 1977